150 related articles for article (PubMed ID: 36499558)
1. EPLIN, a Putative Tumour Suppressor in Colorectal Cancer, Implications in Drug Resistance.
Zeng J; Sanders AJ; Ye L; Hargest R; Ruge F; Jiang WG
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499558
[TBL] [Abstract][Full Text] [Related]
2. Epithelial protein lost in neoplasm-α (EPLIN-α) is a potential prognostic marker for the progression of epithelial ovarian cancer.
Liu R; Martin TA; Jordan NJ; Ruge F; Ye L; Jiang WG
Int J Oncol; 2016 Jun; 48(6):2488-96. PubMed ID: 27035883
[TBL] [Abstract][Full Text] [Related]
3. Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome.
Jiang WG; Martin TA; Lewis-Russell JM; Douglas-Jones A; Ye L; Mansel RE
Mol Cancer; 2008 Sep; 7():71. PubMed ID: 18796137
[TBL] [Abstract][Full Text] [Related]
4. EPLIN-α expression in human oesophageal cancer and its impact on cellular aggressiveness and clinical outcome.
Liu Y; Sanders AJ; Zhang L; Jiang WG
Anticancer Res; 2012 Apr; 32(4):1283-9. PubMed ID: 22493360
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic insights of epithelial protein lost in neoplasm in prostate cancer metastasis.
Collins RJ; Morgan LD; Owen S; Ruge F; Jiang WG; Sanders AJ
Int J Cancer; 2018 Nov; 143(10):2537-2550. PubMed ID: 30098000
[TBL] [Abstract][Full Text] [Related]
6. EPLIN Expression in Gastric Cancer and Impact on Prognosis and Chemoresistance.
Gong W; Zeng J; Ji J; Jia Y; Jia S; Sanders AJ; Jiang WG
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33917939
[TBL] [Abstract][Full Text] [Related]
7. EPLIN: a fundamental actin regulator in cancer metastasis?
Collins RJ; Jiang WG; Hargest R; Mason MD; Sanders AJ
Cancer Metastasis Rev; 2015 Dec; 34(4):753-64. PubMed ID: 26350886
[TBL] [Abstract][Full Text] [Related]
8. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
[TBL] [Abstract][Full Text] [Related]
9. Epithelial Protein Lost in Neoplasm, EPLIN, the Cellular and Molecular Prospects in Cancers.
Zeng J; Jiang WG; Sanders AJ
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356662
[TBL] [Abstract][Full Text] [Related]
10. Epithelial protein lost in neoplasm (EPLIN): Beyond a tumor suppressor.
Wu D
Genes Dis; 2017 Jun; 4(2):100-107. PubMed ID: 30258911
[TBL] [Abstract][Full Text] [Related]
11. MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer.
Cheng LY; Huang MS; Zhong HG; Ru HM; Mo SS; Wei CY; Su ZJ; Mo XW; Yan LH; Tang WZ
World J Surg Oncol; 2022 Aug; 20(1):257. PubMed ID: 35962436
[TBL] [Abstract][Full Text] [Related]
12. Epithelial Protein Lost in Neoplasm alpha (Eplin-alpha) is transcriptionally regulated by G-actin and MAL/MRTF coactivators.
Leitner L; Shaposhnikov D; Descot A; Hoffmann R; Posern G
Mol Cancer; 2010 Mar; 9():60. PubMed ID: 20236507
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Enigma: The Role of the Epithelial Protein Lost in Neoplasm in Normal Physiology and Cancer Pathogenesis.
Lindell E; Zhang X
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732188
[TBL] [Abstract][Full Text] [Related]
14. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
15. Human phosphatase CDC14A regulates actin organization through dephosphorylation of epithelial protein lost in neoplasm.
Chen NP; Uddin B; Hardt R; Ding W; Panic M; Lucibello I; Kammerer P; Ruppert T; Schiebel E
Proc Natl Acad Sci U S A; 2017 May; 114(20):5201-5206. PubMed ID: 28465438
[TBL] [Abstract][Full Text] [Related]
16. TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway.
Wang X; Sun D; Tai J; Chen S; Yu M; Ren D; Wang L
J Exp Clin Cancer Res; 2018 Feb; 37(1):27. PubMed ID: 29439714
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of anchorage-independent growth of transformed NIH3T3 cells by epithelial protein lost in neoplasm (EPLIN) requires localization of EPLIN to actin cytoskeleton.
Song Y; Maul RS; Gerbin CS; Chang DD
Mol Biol Cell; 2002 Apr; 13(4):1408-16. PubMed ID: 11950948
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer.
Guo ST; Jiang CC; Wang GP; Li YP; Wang CY; Guo XY; Yang RH; Feng Y; Wang FH; Tseng HY; Thorne RF; Jin L; Zhang XD
Oncogene; 2013 Apr; 32(15):1910-20. PubMed ID: 22710713
[TBL] [Abstract][Full Text] [Related]
19. Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development.
Piao MY; Cao HL; He NN; Xu MQ; Dong WX; Wang WQ; Wang BM; Zhou B
Scand J Gastroenterol; 2016; 51(5):572-82. PubMed ID: 26691157
[TBL] [Abstract][Full Text] [Related]
20. Exploiting the HSP60/10 chaperonin system as a chemotherapeutic target for colorectal cancer.
Ray AM; Salim N; Stevens M; Chitre S; Abdeen S; Washburn A; Sivinski J; O'Hagan HM; Chapman E; Johnson SM
Bioorg Med Chem; 2021 Jun; 40():116129. PubMed ID: 33971488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
